Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial
- Status
- COMPLETED
- Phase
- NA
A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study
- Status
- WITHDRAWN
- Phase
- N/A
A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Secondary Central Nervous System Lymphoma Registry - Charité
- Status
- RECRUITING
- Phase
- N/A
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
- Status
- RECRUITING
- Phase
- PHASE1
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
- Status
- COMPLETED
- Phase
- N/A
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2